Oestrogens and androgen receptors in oral squamous cell carcinoma

References

• Barnes L, Everson JW, Reichart P, Sidransky D. World Health Organization classification of tumours. Pathology and genetics of head and neck tumors. 1a ed. Lyon: IARC Press; 2005. Cap.5 p 211–12.
   Google Scholar
• Parkin DM, Bray F, Ferlay J Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74–108.
   PubMed Web of Science ®Google Scholar
• Marocchio LS, Lima J, Sperandio FF, Corrêa L, de Sousa SCO. Oral squamous cell carcinoma: an analysis of 1,564 cases showing advances in early detection. J Oral Sci 2010;52:267–73.
   PubMedGoogle Scholar
• Massano J, Regateiro FS, Januário G, Ferreira A. Oral squamous cell carcinoma: review of prognostic and predictive factors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;102:67–76.
   PubMed Web of Science ®Google Scholar
• Carvalho AL, Magrin J, Kowalski LP. Sites of recurrence in oral and oropharyngeal cancers according to the treatment approach. Oral Dis 2003;9:109–11.
   PubMed Web of Science ®Google Scholar
• Brinkmann AO. Molecular basis of androgen insensitivity. Moll Cell Endocrinol 2001;1:105–9.
   Google Scholar
• Ikeda K, Inoue S. Estrogen receptors and their downstream targets in cancer. Arch Histol Cytol 2004;67:435–42.
   Web of Science ®Google Scholar
• Cunat S, Hoffmann P, Pujol P. Estrogens and epithelial ovarian cancer. Gynecol Oncol 2004;94:25–39.
   PubMed Web of Science ®Google Scholar
• Carruba G. Estrogen and prostate cancer: an eclipsed truth in an androgen-dominated scenario. J Cell Biochem 2007;102:899–911.
   PubMed Web of Science ®Google Scholar
• Czajka-Oraniec I, Simpson ER. Aromatase research and its clinical significance. Endokrynol Pol 2010;61:126–34.
   PubMed Web of Science ®Google Scholar
• Tomas C, Gustafsson J. The different roles of ER subtypes in cancer biology and therapy. Nature 2011;11:597–608.
   Web of Science ®Google Scholar
• Valimaa H, Savolainen S, Soukka T, Makela S, Kujari H, Gustafsson JA, et al. Estrogen receptor-beta is the predominant receptor subtype in human oral epithelium and salivary glands. J Endocrinol 2004;180:55–62.
   PubMed Web of Science ®Google Scholar
• Ojanotko-Harri A, Laine M, Hurttia H, Blauer M, Tuohimaa P. Immunohistochemical detection of androgen receptors in human oral mucosa. Arch Oral Biol 1992;37:511–14.
   PubMed Web of Science ®Google Scholar
• Molteni A, Warpeha RL, Brizio Molteni L, Fros EM. Estradiol receptor- binding protein in head and neck neoplastic and normal tissue. Arch Surg 1981;16:207–10.
   Google Scholar
• Dos Santos ML, Sibov TT, Nishimoto IN, Kowalski LP, Miracca EC, Nagai MA. The CAG repeat polymorphism in the androgen receptor gene (AR) and its relationship to head and neck cancer. Oral Oncol 2004;40:177–82.
   PubMed Web of Science ®Google Scholar
• Cheng YS, Mues G, Wood D, Ding J. Aromatase expression in normal human keratinocytes and oral squamous cell carcinoma. Arch Oral Biol 2006;51:612–20.
   PubMed Web of Science ®Google Scholar
• Lukits J, Remenár E, Rásó E, Ladányi A, Kásler M, Tímár J. Molecular identification, expression and prognostic role of estrogen- and progesterone receptors in head and neck cancer. Int J Oncol 2007;30:155–60.
   PubMed Web of Science ®Google Scholar
• Ishida H, Wada K, Masuda T, Okura M, Kohama K, Sano Y, et al. Critical role of estrogen receptor on anoikis and invasion of squamous cell carcinoma. Cancer Sci 2007;98:636–43.
   PubMed Web of Science ®Google Scholar
• Kim MJ, Lee JH, Kim YK, Myoung H, Yun PY. The role of tamoxifen in combination with cisplatin on oral squamous cell carcinoma cell lines. Cancer Lett 2007;245:284–92.
   PubMed Web of Science ®Google Scholar
• Ku TKS, Crowe DL. Coativactor-mediated estrogen response in human squamous cell carcinoma lines. J Endocrinol 2007;193:147–55.
   PubMed Web of Science ®Google Scholar
• Nehse G, Tunn S. Androgen and progesterone receptors in oral carcinoma. J Craniomaxillofac Surg 1994;22:114–19.
   PubMed Web of Science ®Google Scholar
• Schuller DE, Abou-Issa H, Parrish R. Estrogen and progesterone receptors in head and neck cancer. Arch Otolaryngol 1984;110:725–7.
   PubMedGoogle Scholar
• Lukits J, Remenár E, Rásó E, Ladányi A, Kásler M, Tímár J. Molecular identification, expression and prognostic role of estrogen- and progesterone receptors in head and neck cancer. Int J Oncol 2007;30:155–60.
   PubMed Web of Science ®Google Scholar
• Scully C, Bagan J. Oral squamous cell carcinoma: overview of current understanding of aetiopathogenesis and clinical implications. Oral Dis 2009;15:388–99.
   PubMed Web of Science ®Google Scholar
• Rocha R, Nunes C, Rocha G, Oliveira F, Sanches F, Gobbi H. Rabbit monoclonal antibodies show higher sensitivity than mouse monoclonals for estrogen and progesterone receptor evaluation in breast cancer by immunohistochemistry. Pathol Res Pract 2008;204:655–62.
   PubMed Web of Science ®Google Scholar
• Taylor CR, Shi SR, Chaiwun B, Young L, Imam SA, Cote RJ. Strategies for improving the immunohistochemical staining of various intranuclear prognostic markers in formalin-paraffin sections: androgen receptor, estrogen receptor, progesterone receptor, p53 protein, proliferating cell nuclear antigen, and Ki-67 antigen revealed by antigen retrieval techniques. Hum Pathol 1994;25:263–70.
   PubMed Web of Science ®Google Scholar
• Bardin A, Boulle N, Lazennec G, Vignon F, Pujol P. Loss of ERbeta expression as a common step in estrogen-dependent tumor progression. Endocr Relat Cancer 2004;11:537–51.
   PubMed Web of Science ®Google Scholar
• Fixemer T, Remberger K, Bonkhoff H. Differential expression of the estrogen receptor beta (ERbeta) in human prostate tissue, premalignant changes, and in primary, metastatic, and recurrent prostatic adenocarcinoma. Prostate 2003;54:79–87.
   PubMed Web of Science ®Google Scholar
• Roger P, Sahla ME, Mäkelä S, Gustafsson JA, Baldet P, Rochefort H. Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors. Cancer Res 2001;61:2537–41.
   PubMed Web of Science ®Google Scholar
• Skliris GP, Munot K, Bell SM, Carder PJ, Lane S, Horgan K, et al. Reduced expression of oestrogen receptor beta in invasive breast cancer and its re-expression using DNA methyl transferase inhibitors in a cell line model. J Pathol 2003;201:213–20.
   PubMed Web of Science ®Google Scholar
• Goulioumis AK, Fuxe J, Varakis J, Repanti M, Goumas P, Papadaki H. Estrogen receptor-beta expression in human laryngeal carcinoma: correlation with the expression of epithelial-mesenchymal transition specific biomarkers. Oncol Rep 2009;22:1063–8.
   PubMed Web of Science ®Google Scholar
• Hammond ME, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. Arch Pathol Lab Med 2010;134:907–22; Erratum in: Arch Pathol Lab Med 2010;134:1101.
   PubMed Web of Science ®Google Scholar
• Harvey JM, Clark GM, Osborne CK, Allred DC. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol 1999;17:1474–81.
   PubMed Web of Science ®Google Scholar
• Ghosh D, Griswold J, Erman M, Pangborn W. Structural basis for androgen specificity and oestrogen synthesis in human aromatase. Nature 2009;457:219–23.
   PubMed Web of Science ®Google Scholar